시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 전체포도막염 시장 보고서(2025년)
Panuveitis Global Market Report 2025
상품코드 : 1720853
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

전체포도막염 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 투자 증가, 질환에 대한 의식의 고조에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 생물학적 요법의 채용 확대, 서방형 드러그 딜리버리 시스템의 개발, 맞춤형 의료 어프로치의 확대, AI를 활용한 진단 및 치료의 진보, 저침습 수술 기술의 대두 등이 있습니다.

자가면역 질환의 유병률 증가는 향후 몇 년간의 전체포도막염 시장의 성장을 가속할 것으로 예측됩니다. 유병률의 상승은 유전적 소인, 오염이나 식생활의 변화 등의 환경적 영향, 면역계 조절 부전의 트리거가 되는 감염증이나 스트레스 요인에 대한 추가 노출 등의 요인에 기인하고 있습니다. 자가면역 질환은 자가면역 활동과 관련된 많은 사례들로 인해 면역 체계 조절에 대한 연구를 촉진함으로써 판뉴브염 치료를 발전시키고 있습니다. 2023년 5월에 영국에 본사를 둔 연구 기관인 옥스퍼드 대학교는 자가면역 질환이 세계 인구의 10%에 영향을 미치고, 여성의 13%, 남성의 7%가 영향을 받고 있다고 보고했습니다.

전체포도막염 시장의 주요 기업은 환자의 컴플라이언스와 치료 효과를 높이기 위해 첨단 서방형 유리 체내 주사 제제의 개발을 우선하고 있습니다. 체액 중에 투여하는 약물전달 시스템으로, 빈번한 투여의 필요성을 최소화하면서 치료 효과를 지속시키고 있습니다. Pharma는 망막질환 치료를 위한 잠재적인 면역조절제인 TRS02의 개발을 발표했습니다. 질병에 대처하도록 설계되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Panuveitis is an inflammatory condition that affects all three layers of the uvea include the iris, ciliary body, and choroid within the eye. If left untreated, it can cause pain, blurred vision, and potentially lead to vision loss. The primary goal of treatment is to control inflammation, alleviate symptoms, and prevent further eye damage that could impair vision. Timely intervention is crucial for maintaining eye health and preserving sight.

The main types of panuveitis include infectious and non-infectious panuveitis. Infectious panuveitis is caused by infectious agents and requires prompt diagnosis and treatment to prevent severe eye complications and vision impairment. Treatment options include pharmacological therapy, surgical interventions, and phototherapy, administered via oral, intravitreal, and topical routes. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, ensuring accessibility for patients.

The panuveitis market research report is one of a series of new reports from The Business Research Company that provides panuveitis market statistics, including the panuveitis industry global market size, regional shares, competitors with the panuveitis market share, detailed panuveitis market segments, market trends, and opportunities, and any further data you may need to thrive in the panuveitis industry. This panuveitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The panuveitis market size has grown rapidly in recent years. It will grow from $4.05 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the prevalence of autoimmune and infectious diseases, the increasing use of corticosteroids, the rising adoption of biologics, the growing demand for ophthalmic imaging, and expanding research investment in infectious causes.

The panuveitis market size is expected to see rapid growth in the next few years. It will grow to $6.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the expanding use of biologic therapies, increasing demand for personalized medicine, the rising prevalence of uveitis-linked diseases, higher investments in ophthalmic research, and growing disease awareness. Major trends expected during this period include the increasing adoption of biologic therapies, the development of sustained-release drug delivery systems, the expansion of personalized medicine approaches, advancements in AI-driven diagnosis and treatment, and the rise of minimally invasive surgical techniques.

The increasing prevalence of autoimmune disorders is expected to drive the growth of the panuveitis market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. This rising prevalence is attributed to factors such as genetic predisposition, environmental influences such as pollution and dietary changes, and greater exposure to infections and stressors that can trigger immune system dysregulation. Autoimmune disorders are advancing panuveitis treatment by promoting research into immune system modulation, as many cases of panuveitis are linked to autoimmune activity. For instance, in May 2023, the University of Oxford, a UK-based research institution, reported that autoimmune disorders affect 10% of the global population, with 13% of women and 7% of men impacted. As a result, the increasing occurrence of autoimmune disorders is fueling the expansion of the panuveitis market.

Leading companies in the panuveitis market are prioritizing the development of advanced slow-release intravitreal injection formulations to enhance patient compliance and treatment effectiveness. A slow-release intravitreal injection formulation is a drug delivery system that gradually administers medication into the eye's vitreous humor over an extended period, ensuring sustained therapeutic effects while minimizing the need for frequent dosing. For example, in August 2022, Tarsier Pharma, an Israel-based clinical-stage company, announced the development of TRS02, a potential immunomodulator for the treatment of retinal diseases. This innovative therapy is designed to address various back-of-the-eye conditions with inflammatory pathologies, including posterior uveitis (panuveitis) and diabetic macular edema. TRS02, developed using Tarsier's proprietary technology platform, is advancing toward investigational new drug (IND) submission following successful preclinical milestones.

In July 2023, Harrow Health Inc., a US-based pharmaceutical company, acquired Santen Pharmaceutical Co., Ltd. for an undisclosed sum. This acquisition enables Harrow to expand its portfolio by integrating Santen's expertise in developing innovative treatments for uveitis and panuveitis. Santen Pharmaceutical Co. Ltd., a Japan-based company, specializes in treatments for panuveitis.

Major players in the panuveitis market are Pfizer Inc., AbbVie, Boehringer Ingelheim International GmbH, Amgen, Teva Pharmaceuticals, Sandoz, Organon group of companies, Zydus Lifesciences Ltd., Mallinckrodt plc, Alvotech, EyePoint Pharmaceuticals Inc., Affibody Medical AB, Alumis Inc., Fujifilm Kyowa Kirin Biologics Co. Ltd., Revolo Biotherapeutics Ltd., Tarsier Pharma, Priovant Therapeutics Inc., Mylan N.V., Clearside Biomedical Inc., pSivida Corp.

North America was the largest region in the panuveitis market in 2024. The regions covered in panuveitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the panuveitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The panuveitis market consists of revenues earned by entities providing services such as pharmaceutical treatment, surgical interventions, diagnostic services, and supportive care. The market value includes the value of related goods sold by the service providers or included within the service offering. The panuveitis market also includes sales of diagnostic tools, pharmaceuticals, biologic agents, immunosuppressive drugs, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panuveitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panuveitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for panuveitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panuveitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Panuveitis Market Characteristics

3. Panuveitis Market Trends And Strategies

4. Panuveitis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Panuveitis Growth Analysis And Strategic Analysis Framework

6. Panuveitis Market Segmentation

7. Panuveitis Market Regional And Country Analysis

8. Asia-Pacific Panuveitis Market

9. China Panuveitis Market

10. India Panuveitis Market

11. Japan Panuveitis Market

12. Australia Panuveitis Market

13. Indonesia Panuveitis Market

14. South Korea Panuveitis Market

15. Western Europe Panuveitis Market

16. UK Panuveitis Market

17. Germany Panuveitis Market

18. France Panuveitis Market

19. Italy Panuveitis Market

20. Spain Panuveitis Market

21. Eastern Europe Panuveitis Market

22. Russia Panuveitis Market

23. North America Panuveitis Market

24. USA Panuveitis Market

25. Canada Panuveitis Market

26. South America Panuveitis Market

27. Brazil Panuveitis Market

28. Middle East Panuveitis Market

29. Africa Panuveitis Market

30. Panuveitis Market Competitive Landscape And Company Profiles

31. Panuveitis Market Other Major And Innovative Companies

32. Global Panuveitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Panuveitis Market

34. Recent Developments In The Panuveitis Market

35. Panuveitis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기